The Scientific Research and Development team at NextPoint Therapeutics, Inc. spearheads the discovery, design, and development of innovative immunotherapies. This includes conducting advanced research to identify new therapeutic targets, developing antibody technologies, and translating preclinical findings into potential clinical candidates to enhance the efficacy of cancer immunotherapies independent of PD-1/L1 pathways.